New gadget aims to take the guesswork out of measuring skin hardening in scleroderma

NCT ID NCT07543679

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study is testing a new device called ADHELASKIN to see if it can measure skin stiffness more accurately than the current method (feeling the skin by hand) in people with systemic sclerosis (scleroderma). The study will compare 100 participants: those with scleroderma and healthy volunteers. The goal is to find a more objective and reliable way to track skin damage, which could improve how doctors monitor the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for D013493 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Saint-Etienne

    RECRUITING

    Saint-Priest-en-Jarez, Pays de la Loire Region, 42270, France